share_log

康諾亞-B:自願性公告 CM310治療慢性鼻竇炎伴鼻息肉的III期臨床試驗達到主要終點

KEYMED BIO-B: VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF CM310 FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ACHIEVED PRIMARY ENDPOINTS

香港交易所 ·  Dec 26, 2023 19:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more